Naringin reduces body weight, plasma lipids and increases adiponectin levels in patients with dyslipidemia

International journal for vitamin and nutrition research. Internationale Zeitschrift für Vitamin- und Ernährungsforschung. Journal international de vitaminologie et de nutrition
Jessica Lucia Barajas-VegaErnesto Javier Ramirez-Lizardo

Abstract

Naringin is a citrus-flavonoid which has been shown to have positive metabolic and anti-inflammatory effects. For this reason, we believe it would be interesting to study the effects of Naringin administration on body weight, BMI, lipid profile and adiponectin levels in patients with dyslipidemia, especially considering that dyslipidemias along with obesity and subsequent cardiometabolic complications are some of the most important public health issues plaguing our society today. A double-blind, randomized clinical trial was conducted in a group of 28 adult patients previously diagnosed with dyslipidemia who attended the Institute of Experimental and Clinical Therapeutics. Patients were divided into two groups; the first group (n = 14) received 450 mg of naringin every 24 hours, in the mornings, while the second group (n = 14) was given a homologated placebo over the course of a 90-day period. Significant differences were observed in naringin group compared to the placebo group in terms of decreased BMI (30.6 ± 3.19 vs 33.3 ± 3.23 kg/m2; p = 0.03), total cholesterol (182 ± 20.2 vs 245 ± 24.1 mg/dl; p < 0.01), LDL cholesterol (100 ± 17.5 vs 125 ± 38.3 mg/dl; p = 0.03) and an increase in adiponectin levels (0.82 ± 0.25 vs 0.59 ± ...Continue Reading

References

May 2, 2003·Journal of Agricultural and Food Chemistry·Rebecca J Robbins
Nov 14, 2003·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·U J JungM S Choi
Nov 19, 2003·Life Sciences·Machha AjayMohd Rais Mustafa
Feb 16, 2010·Journal of the American College of Cardiology·Ara TachjianArshad Jahangir
Dec 10, 2013·The Journal of Nutritional Biochemistry·Shu WangChwan-Li Shen
Apr 9, 2014·Planta medica·Saurabh BhartiDharamvir Singh Arya
Jun 22, 2016·Nutrition·Amirhossein SahebkarMaciej Banach
Aug 27, 2016·Pharmaceutical Biology·Rui ChenQi-Yan Li
Mar 21, 2017·Current Pharmaceutical Design·Angelo M PattiManfredi Rizzo
Sep 2, 2017·Journal of the American College of Cardiology·Robert S RosensonPaul D Thompson
Sep 9, 2017·Archives of Medical Science : AMS·Arrigo F G CiceroMaciej Banach
Sep 14, 2017·Salud pública de México·Martín Romero-MartínezMauricio Hernández-Ávila
Oct 27, 2017·Nutrients·Priscila Silva FigueiredoPriscila Aiko Hiane
Nov 10, 2017·Current Pharmaceutical Design·Kirsty A WoodwardDavid A Low
Dec 13, 2017·Canadian Journal of Diabetes·Ravindran JaganathanSugapriya Dhanasekaran
Nov 6, 2018·Life Sciences·Ruthvika JoshiSarika Wairkar

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

SPSS

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.